Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 589-601

  De Chambrun, G Pineton ^a,b,c   Body Malapel, M ^a,b   Frey Wagner, I ^d   Djouina, M ^a,b   Deknuydt, F ^e,f,g   Atrott, K ^d   Esquerre, N ^a,b   Altare, F ^e,f,g   Neut, C ^a,b,h   Arrieta, M C ⁱ   Kanneganti, T D ^j   Rogler, G ^d   Colombel, J F ^a,b,c   Cortot, A ^a,b,c   Desreumaux, P ^a,b,c   Vignal, C ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Département de Recherche en Cancérologie Nantes Angers   (France)

^f UMR 6299   (France)

^g UNIVERSITÉ DE NANTES   (France)

^h Department of Pharmacy Practice   (France)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM CITRATE; ALUMINUM PHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; MYELOPEROXIDASE; ALUMINUM; ALUMINUM DERIVATIVE; AUTACOID; CYTOKINE; PHOSPHATE; TRINITROBENZENESULFONIC ACID;

ALUMINUM OVERLOAD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CELL RENEWAL; COLITIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; ENZYME ACTIVITY; ESCHERICHIA COLI; ESCHERICHIA COLI K 12; EX VIVO STUDY; GRANULOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING; ANIMAL; CELL LINE; CHEMICALLY INDUCED; CHRONIC DISEASE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ALUMINUM; ALUMINUM COMPOUNDS; ANIMALS; CELL LINE; CHRONIC DISEASE; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GRANULOMA; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINAL MUCOSA; MALE; MICE; MICE, KNOCKOUT; PHOSPHATES; TRINITROBENZENESULFONIC ACID; WOUND HEALING;

EID: 84899580331     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.78     Document Type: Article

References (52)

1. Abraham, C. & Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140, 1729-1737 (2011).
2. Kabi, A., Nickerson, K.P., Homer, C.R. & McDonald, C. Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis 18, 782-792 (2012).
3. Kaser, A., Zeissig, S. & Blumberg, R.S. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis 28, 395-405 (2010).
4. Molodecky, N.A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54. e42; quiz e30 (2012).
5. Pinsk, V., Lemberg, D.A., Grewal, K., Barker, C.C., Schreiber, R.A. & Jacobson, K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 102, 1077-1083 (2007).
6. Cosnes, J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18, 481-496 (2004).
7. Cosnes, J., Carbonnel, F., Beaugerie, L., Blain, A., Reijasse, D. & Gendre, J.P. Effects of appendicectomy on the course of ulcerative colitis. Gut 51, 803-807 (2002).
8. De Vroey, B., De Cassan, C., Gower-Rousseau, C. & Colombel, J.F. Editorial: Antibiotics earlier, IBD later? Am JGastroenterol 105, 2693-2696 (2010).
9. Hviid, A., Svanstrom,H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49-54 (2011).
10. Kaplan, G.G. et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am JGastroenterol 105, 2412-2419 (2010).
11. Ananthakrishnan, A.N., McGinley, E.L., Binion, D.G. & Saeian, K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis 17, 1138-1145 (2011).
12. Becaria, A.,Campbell, A. & Bondy,S.C.Aluminum as a toxicant. Toxicol Ind Health 18, 309-320 (2002).
13. Nayak, P. Aluminum: impacts and disease. Environ Res 89, 101-115 (2002).
14. Keith, S. Toxicological profile: aluminum. US department of health and human services. Public health service. Agency for toxic substances and disease registry (2008) http://wwwatsdrcdcgov/toxprofiles/tpasp?id= 191&tid=34.
15. Gourier-Frery, C.F.N. et al. Aluminuim: Quels risques pour la santé? Synthese des études épidémiologiques. Volet épidémiologiques de l'expertise collective InVS-Afssa-Afssaps. Institut de veille sanitaire (2003) http://wwwinvssantefr/publications/2003/ aluminium-2003/.
16. Greger, J.L. & Sutherland, J.E. Aluminum exposure and metabolism. Crit Rev Clin Lab Sci 34, 439-474 (1997).
17. Lerner, A. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis. Ann NY Acad Sci 1107, 329-345 (2007).
18. Zaki, M.H.,Boyd,K.L.,Vogel,P.,Kastan, M.B., Lamkanfi,M.& Kanneganti,T.D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010).
19. Puissegur, M.P., Botanch, C., Duteyrat, J.L., Delsol, G., Caratero, C. & Altare, F. An in vitro dual model ofmycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 6, 423-433 (2004).
20. Meconi, S. et al. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cell Microbiol 9, 1252-1261 (2007).
21. Taylor, G.A., Moore, P.B., Ferrier, I.N., Tyrer, S.P. & Edwardson, J.A. Gastrointestinal absorption of aluminium and citrate in man. J Inorg Biochem 69, 165-169 (1998).
22. Meyer-Baron, M., Schaper, M., Knapp, G. & van Thriel, C. Occupational aluminum exposure: evidence in support of its neurobehavioral impact. Neurotoxicology 28, 1068-1078 (2007).
23. Malluche, H.H. Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant 17 (Suppl 2), 21-24 (2002).
24. Cunat, L., Lanhers, M.C., Joyeux, M. & Burnel, D. Bioavailability and intestinal absorption of aluminum in rats: effects of aluminum compounds and some dietary constituents. Biol Trace Elem Res 76, 31-55 (2000).
25. Powell, J.J., Ainley, C.C., Evans, R. & Thompson, R.P. Intestinal perfusion of dietary levels of aluminium: association with the mucosa. Gut 35, 1053-1057 (1994).
26. Shepherd, N.A., Crocker, P.R., Smith, A.P. & Levison, D.A. Exogenous pigment in Peyer's patches. Hum Pathol 18, 50-54 (1987).
27. Urbanski, S.J., Arsenault, A.L., Green, F.H. & Haber, G. Pigment resembling atmospheric dust in Peyer's patches. Mod Pathol 2, 222-226 (1989).
28. Powell, J.J. et al. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38, 390-395 (1996).
29. Fogarty, U., Perl, D., Good, P., Ensley, S., Seawright, A. & Noonan, J. A cluster of equine granulomatous enteritis cases: the link with aluminium. Vet Hum Toxicol 40, 297-305 (1998).
30. Lerner, A.E.S. & Perl, D. et al. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice (abstract). Gastroenterology 130, 362-363 (2006).
31. Burrell, S.A. & Exley,C. There is (still) too much aluminium in infant formulas. BMC Pediatr 10, 63 (2010).
32. Sly, P.D. & Flack, F. Susceptibility of children to environmental pollutants. Ann NY Acad Sci 1140, 163-183 (2008).
33. Greger, J.L. Dietary and other sources of aluminium intake. Ciba Found Symp 169, 26-35. discussion-49 (1992).
34. Aspenstrom-Fagerlund, B., Sundstrom, B., Tallkvist, J., Ilback, N.G. & Glynn, A.W. Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers. Chem Biol Interact 181, 272-278 (2009).
35. Exley, C., Siesjo, P. & Eriksson, H. The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol 31, 103-109 (2010).
36. Vogelbruch, M., Nuss, B., Korner, M., Kapp, A., Kiehl, P. & Bohm, W. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 55, 883-887 (2000).
37. Chen, W.J., Monnat, R.J. Jr., Chen, M. & Mottet, N.K. Aluminum induced pulmonary granulomatosis. Hum Pathol 9, 705-711 (1978).
38. Perl, D.P., Fogarty, U., Harpaz, N. & Sachar, D.B. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis 10, 881-883 (2004).
39. Exley, C. et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler 12, 533-540 (2006).
40. Exley, C., Swarbrick, L., Gherardi, R.K. & Authier, F.J. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 72, 135-139 (2009).
41. Sandstrom, R.E. Aluminum induced pulmonary granulomatosis. Hum Pathol 10, 481 (1979).
42. van der Voet, G.B., Dijkmans, B.A., Frankfort, C. & de Wolff, F.A. Elevation of serum aluminium concentrations in patients with rheumatoid arthritis treated with drugs containing aluminium. Br J Rheumatol 28, 144-146 (1989).
43. Roediger, W.E. & Babidge, W. Human colonocyte detoxification. Gut 41, 731-734 (1997).
44. Kaminsky, L.S. & Zhang, Q.Y. The small intestine as a xenobioticmetabolizing organ. Drug Metab Dispos 31, 1520-1525 (2003).
45. Brant, S.R. et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73, 1282-1292 (2003).
46. Langmann, T. et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127, 26-40 (2004).
47. Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M.F. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2, 541-546 (2007).
48. Ameho, C.K. et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 41, 487-493 (1997).
49. Yan, Y. et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE 4, e6073 (2009).
50. Obermeier, F.,Kojouharoff, G.,Hans,W.,Scholmerich, J., Gross,V.& Falk,W. Interferon-gamma (IFN-gamma)-and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 116, 238-245 (1999).
51. Becker, C., Fantini, M.C. & Neurath, M.F. High resolution colonoscopy in live mice. Nat Protoc 1, 2900-2904 (2006).
52. Anton, P.M. et al. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci USA 101, 8503-8508 (2004).